JPRN-jRCT2080223247已完成3 期
A Phase III , open-label study of KRP-AM1977Y for patients with respiratory tract infection
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 78
研究概览
简要总结
KRP-AM1977Y was highly effective for Secondary infection of chronic respiratory disease, Aspiration pneumonia, and Lung abscess. In the safety assessment, no clinically significant finding was reported in KRP-AM1977Y.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Respiratory tract infection with clear infection symptoms
排除标准
- •Patient with hypersensitivity to quinolone antibacterial agent
- •Patient with serious functional disorder that would unsuitable for the study
- •Patient showing the tendency to improve pneumonia symptoms by other agents
研究者
相似试验
已完成
3 期
KRP-AM1977X Phase III Open-label Study (Respiratory Tract Infection)Secondary infection of chronic respiratory disease and acute bronchitisJPRN-jRCT2080222861Kyorin Pharmaceutical Co.,LTD53
已完成
3 期
Open-label study for the patients with otorhinolaryngological infectionJPRN-jRCT2080222863Kyorin Pharmaceutical Co.,LTD70
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacology study)JPRN-jRCT2080222496Kyorin Pharmaceutical Co.,LTD31
已完成
3 期
KRP-AM1977X Phase III Comparative Study (sinusitis)Sinusitis (severity of infection: moderate to severe)JPRN-jRCT2080222862Kyorin Pharmaceutical Co.,LTD279
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjectsJPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54